140 related articles for article (PubMed ID: 29483142)
1. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.
Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT
Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142
[No Abstract] [Full Text] [Related]
2. Dynamic regulation of Rad51 by E2F1 and p53 in prostate cancer cells upon drug-induced DNA damage under hypoxia.
Wu M; Wang X; McGregor N; Pienta KJ; Zhang J
Mol Pharmacol; 2014 Jun; 85(6):866-76. PubMed ID: 24627085
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination.
Adimoolam S; Sirisawad M; Chen J; Thiemann P; Ford JM; Buggy JJ
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19482-7. PubMed ID: 18042714
[TBL] [Abstract][Full Text] [Related]
4. CircCDYL2 bolsters radiotherapy resistance in nasopharyngeal carcinoma by promoting RAD51 translation initiation for enhanced homologous recombination repair.
Qu H; Wang Y; Yan Q; Fan C; Zhang X; Wang D; Guo C; Chen P; Shi L; Liao Q; Zhou M; Wang F; Zeng Z; Xiang B; Xiong W
J Exp Clin Cancer Res; 2024 Apr; 43(1):122. PubMed ID: 38654320
[TBL] [Abstract][Full Text] [Related]
5. PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility.
Jing N; Du X; Liang Y; Tao Z; Bao S; Xiao H; Dong B; Gao WQ; Fang YX
J Exp Clin Cancer Res; 2024 May; 43(1):144. PubMed ID: 38745318
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin induces senescence and repression of DNA repair via downregulation of Rad51.
Chen F; Zhao W; Du C; Chen Z; Du J; Zhou M
Mol Med; 2024 Apr; 30(1):54. PubMed ID: 38649802
[TBL] [Abstract][Full Text] [Related]
7. miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway.
Jiang T; Chen J; Wang Z; Wang X; Ma J; Zhao F; Huang C; Chen Y
Breast Cancer; 2023 Sep; 30(5):691-702. PubMed ID: 37460775
[TBL] [Abstract][Full Text] [Related]
8. The miR-99 family regulates the DNA damage response through its target SNF2H.
Mueller AC; Sun D; Dutta A
Oncogene; 2013 Feb; 32(9):1164-72. PubMed ID: 22525276
[TBL] [Abstract][Full Text] [Related]
9. Primary Vestibular Schwannoma Cells Activate p21 and RAD51-Associated DNA Repair Following Radiation-Induced DNA Damage.
Thielhelm TP; Goncalves S; Welford S; Mellon EA; Bracho O; Estivill M; Brown C; Morcos J; Ivan ME; Telischi F; Fernandez-Valle C; Dinh CT
Otol Neurotol; 2021 Dec; 42(10):e1600-e1608. PubMed ID: 34420024
[TBL] [Abstract][Full Text] [Related]
10. Dynamic role of CUL4B in radiation-induced intestinal injury-regeneration.
Guo B; Huo X; Xie X; Zhang X; Lian J; Zhang X; Gong Y; Dou H; Fan Y; Mao Y; Wang J; Hu H
Sci Rep; 2024 Apr; 14(1):9906. PubMed ID: 38689033
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.
Bindra RS; Schaffer PJ; Meng A; Woo J; Måseide K; Roth ME; Lizardi P; Hedley DW; Bristow RG; Glazer PM
Mol Cell Biol; 2004 Oct; 24(19):8504-18. PubMed ID: 15367671
[TBL] [Abstract][Full Text] [Related]
12. Definitive evidence using enucleated cytoplasts for a nongenomic basis for the cystic change in endoplasmic reticulum structure caused by STAT5a/b siRNAs.
Lee JE; Yang YM; Yuan H; Sehgal PB
Am J Physiol Cell Physiol; 2013 Feb; 304(4):C312-23. PubMed ID: 23151802
[TBL] [Abstract][Full Text] [Related]
13. TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy.
Pirovano G; Ashton TM; Herbert KJ; Bryant RJ; Verrill CL; Cerundolo L; Buffa FM; Prevo R; Harrap I; Ryan AJ; Macaulay V; McKenna WG; Higgins GS
Br J Cancer; 2017 Aug; 117(4):503-512. PubMed ID: 28677687
[TBL] [Abstract][Full Text] [Related]
14. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells.
Holley AK; Xu Y; St Clair DK; St Clair WH
Ann N Y Acad Sci; 2010 Jul; 1201():129-36. PubMed ID: 20649549
[TBL] [Abstract][Full Text] [Related]
15. Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.
Hine CM; Seluanov A; Gorbunova V
Mol Ther; 2012 Feb; 20(2):347-55. PubMed ID: 22008909
[TBL] [Abstract][Full Text] [Related]
16. Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments.
Packer JR; Hirst AM; Droop AP; Adamson R; Simms MS; Mann VM; Frame FM; O'Connell D; Maitland NJ
FEBS Lett; 2020 Jan; 594(2):209-226. PubMed ID: 31468514
[TBL] [Abstract][Full Text] [Related]
17. Molecularly targeted radiosensitization chances towards gene aberration-due organ confined/regionally advanced prostate cancer radioresistance.
Alberti C
G Chir; 2015; 36(3):133-6. PubMed ID: 26188759
[TBL] [Abstract][Full Text] [Related]
18. [RAD51 at the heart of the balance between cancer and aging].
Matos-Rodrigues G; Lopez BS; Martini E
Med Sci (Paris); 2024 Mar; 40(3):234-237. PubMed ID: 38520095
[No Abstract] [Full Text] [Related]
19. Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancer.
Paczkowski M; Kretzschmar WW; Markelc B; Liu SK; Kunz-Schughart LA; Harris AL; Partridge M; Byrne HM; Kannan P
Commun Biol; 2021 Jan; 4(1):6. PubMed ID: 33398023
[TBL] [Abstract][Full Text] [Related]
20. Pathological polyploidy and liver repair failure in RAD51-deficient mice.
Duncan AW
Hepatology; 2024 Mar; ():. PubMed ID: 38546299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
